Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 3CNS 2Head & Neck 1Gynecologic 1Endocrine 1Dermatologic 1

Conditions

Squamous Cell Carcinoma of Head and Neck 96Head and Neck Neoplasms 73Carcinoma, Non-Small-Cell Lung 34Thyroid Neoplasms 29Melanoma 26Ovarian Neoplasms 25Mouth Neoplasms 23Colorectal Neoplasms 20Oropharyngeal Neoplasms 19Breast Neoplasms 18Uterine Cervical Neoplasms 16Carcinoma, Squamous Cell 16Nasopharyngeal Carcinoma 15Lung Neoplasms 15Carcinoma, Renal Cell 15Neoplasm Metastasis 14Urinary Bladder Neoplasms 13Stomach Neoplasms 13Sarcoma 13Laryngeal Neoplasms 13Triple Negative Breast Neoplasms 12Prostatic Neoplasms 12Carcinoma 12Esophageal Neoplasms 11Endometrial Neoplasms 11Neoplasms 10Pancreatic Neoplasms 9Hypopharyngeal Neoplasms 9Salivary Gland Neoplasms 8Carcinoma, Transitional Cell 7

Interventions

capivasertib 1Taxes 1Paclitaxel 1Immunoglobulin G 1Disulfides 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Chondrosarcoma × Head & Neck × 30 days × Clear all
NCT05039801 2026-06-01

IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors

M.D. Anderson Cancer Center

Phase 1 Recruiting
54 enrolled
DermatologicGynecologicHead & NeckSarcoma

Squamous Cell Carcinoma of Head and Neck, Chondrosarcoma, Melanoma, Ovarian Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡